Stergios A Polyzos1, Evangelos Terpos2. Show Affiliations » 1. School of Medicine, University of Athens, Athens, Greece. stergios@endo.gr. 2. School of Medicine, University of Athens, Athens, Greece.
Abstract
Entities: Chemical Disease
Mesh: See more » Bone Density Conservation Agents/therapeutic useDenosumab/therapeutic useFemaleHumansMiddle AgedOsteoporosis/complicationsOsteoporosis/drug therapyOsteoporotic Fractures/etiologySpinal Fractures/etiologyWithholding Treatment
Substances: See more » Bone Density Conservation AgentsDenosumab
Year: 2016 PMID: 27393301 DOI: 10.1007/s12020-016-1030-6
Source DB: PubMed Journal: Endocrine ISSN: 1355-008X Impact factor: 3.633